Search results
The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – July 1, 2022 – Zacks.com announces the list of stocks featured...
The Zacks Analyst Blog Highlights AbbVie, Novartis, Merck and AstraZeneca
Zacks via Yahoo Finance· 2 years agoFor Immediate Release Chicago, IL – September 19, 2022 – Zacks.com announces the list of stocks...
Pharma Stock Roundup: ABBV to Buy Immunogen, NVS Ups Mid-Term Sales View & More
Zacks via Yahoo Finance· 5 months agoThis week, AbbVie ABBV announced a definitive agreement to acquire cancer biotech Immunogen at a...
GSK, Novartis pledge funds for diseases that mostly affect the poor
Reuters via Yahoo News· 2 years agoLONDON (Reuters) -GSK and Novartis reinforced commitments on Thursday to tackle neglected tropical...
Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short.
Investor's Business Daily· 3 months agoTeva stock neared a profit-taking zone Wednesday, while GSK stock — a fellow pharma Goliath —...
Emergent's (EBS) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo Finance· 1 year agoEmergent BioSolutions Inc. EBS reported an adjusted loss of $1.27 per share in third-quarter 2022,...
Pharma Stock Roundup: NVS, MRK Report Q3 Earnings JNJ's Tecvayli Gets FDA Nod
Zacks via Yahoo Finance· 2 years agoThis week, Novartis NVS and Merck MRK announced their third-quarter earnings. The FDA approved J&J’s...
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Zacks via Yahoo Finance· 1 week agoThe first-quarter 2024 earnings season picked up pace this week, with Merck MRK, Sanofi SNY,...
Sanofi (SNY) Beats on Q2 Earnings, Misses Sales, Stock Down
Zacks via Yahoo Finance· 9 months agoSanofi SNY reported second-quarter 2023 adjusted earnings of 99 cents per American depositary share,...
Emergent Biosolutions (EBS) Down 20% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Emergent Biosolutions (EBS). Shares have lost...